Merck Confident With Legacy Innovation In Japan And Emerging Markets - JP Morgan Healthcare Conference
This article was originally published in PharmAsia News
TOKYO - Merck has been quite vocal in recent months about shifting its focus to emerging markets, but the company is also expecting big gains in Japan due to a slate of upcoming market launches
You may also be interested in...
MUMBAI - Merck CEO designate Kenneth Frazier's visit to India accompanied by key global leaders earlier this month sparked rumors that takeover of a large Indian company could be on Merck's wish list and Cipla - the largest home-grown company by market share - may be the likely target on the Big Pharma's radar
As Merck looks to expand its geographic footprint in emerging markets, local players with extensive distribution networks will be the focus for partnerships, Merck Chief Strategy Officer and former Emerging Markets R&D Head Mervyn Turner told investors at the CLSA Emerging Markets Pharma Conference Dec.1 in New York
Pfizer, Merck Execs Share Emerging Markets Strategies - Windhover's Pharmaceutical Strategic Alliances Conference (Part 1 of 2)
NEW YORK - Emerging markets will account for almost half of the global pharmaceutical market growth through 2014, according to IMS Health VP Rob Arnold